OTCPK:GBGPF - Post by User
Comment by
StrongLongon Jan 15, 2018 5:55pm
119 Views
Post# 27363168
RE:RE:RE:RE:RE:RE:RE:thorgb1 - Most ACB holders not bashing
RE:RE:RE:RE:RE:RE:RE:thorgb1 - Most ACB holders not bashingDemian72 wrote: StrongLong wrote: Mazzanazzam wrote:
Well put!
Certain people don't seem to understand the deal unfortunately...The longer the deal doesn't happen, the less the CMED share is actually going to be worth as ACB increases (unless the deal doesn't happen at all).
That's why the offer is a bad one... remove the 24 cap and it's a good offer.
CMED will do just fine without Aurora.. the only thing they are short on is production which is why the Newstrike deal makes a ton of sense. CMED plus Newstrike present day production is actually greater than Aurora. CMED is a leader in oils and have a license to export to Germany for their medical system. Short term aside... CMED will be booming in the long run. As will the whole sector, but to make statements like "15 years in the business still haven't figured it out" is just ignorant. They have a different approach. Aurora wants to grow as rapidly as it can and absorb as much market share as possible. They've sourced solutions rather than develop in house. In the long run is this the road to low cost production? Time will tell... certainly volume is more important than margin to Aurora.
There is more than one way to skin a cat.
Well, has it not occured to you that if your outline of the CMED's strategy was indeed a sound way to skin a cat, the 38 % of shareholders (all investment funds) would not have revolted against the cat skinner?
perhaps the terms of their agreement are better than the 4.5:1 $24 cap limit offer?